Keyword: cancer

Chemistry & Life Sciences

The Success Story of Biosimilars

13.09.2023 -

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...

News

Gilead Partners with Tentarix on Cancer and Inflammation Therapies

17.08.2023 -

Gilead Sciences and Tentarix Biotherapeutics established three multi-year collaborations using Tentarix’s proprietary Tentacles platform to discover and develop multi...

News

Bayer and Bicycle in Cancer Collaboration

16.05.2023 -

Bayer and UK biotech Bicycle Therapeutics have agreed to collaborate to develop and commercialize the latter’s radioconjugates for multiple oncology targets.

News

BioNTech and DualityBio Sign ADC Rights Deal

14.04.2023 -

German biotech and Covid vaccine maker BioNTech has sealed a major deal with Chinese biotech DualityBio to co-develop and commercialize two cancer antibody drug...

News

Plaintiffs Reject newest J&J Talc Litigation Offer

06.04.2023 -

Seeking to clear billions of dollars worth of litigation claiming that its iconic baby powder causes cancer, Johnson & Johnson has announced it is now prepared to offer a...

News

Pfizer Takes Seagen for $43 Billion

15.03.2023 -

Pfizer has agreed to acquire Seagen, a global biotech focused on developing cancer treatments, for $43 billion. The announcement comes just a couple of weeks after the...

News

Sumitovant Closes Myovant Purchase

15.03.2023 -

US biopharma Sumitovant – a wholly owned subsidiary of Japan’s Sumitomo Pharma – has closed its purchase of the remaining equity in Myovant Sciences, taking full control...

News

Adaptimmune and TCR2 Agree Merger

13.03.2023 -

Clinical stage biotechs Adaptimmune and TCR2 Therapeutics have agreed to merge, forming what they said would be a “preeminent cell therapy company focused on creating...